Dr. Amy Brower is a Clinical Professor in the Department of Health Professions at the Creighton University School of Medicine in Omaha, Nebraska. Dr. Brower is a medical geneticist and, for sixteen years, was the Principal Investigator of the NBSTRN, part of the NICHD’s Hunter Kelly Newborn Screening Research Program, at the American College of Medical Genetics and Genomics. She led a team focusing on informatics platforms to enhance the understanding of genetic diseases by managing clinical and genomic data. The NBSTRN, in collaboration with various national research efforts, aims to advance newborn and child health through projects like genome sequencing and Duchenne Muscular Dystrophy early detection. Dr. Brower’s extensive research background includes participation in the Human Genome and International HapMap Projects, molecular diagnostics development, and medical device industry contributions. She served on numerous advisory boards and was a founding member of the Secretary’s Advisory Committee on Heritable Disorders in Newborns and Children. Dr. Brower earned her doctorate in Medical Genetics at the University of Nebraska Medical Center. Amy is a parent to a son with Severe Combined Immunodeficiency.
Research Keywords & Expertise
Genomics
Precision Medicine
Rare disease
Newborn screening rese...
Longitudinal follow-up
Short Biography
Dr. Amy Brower is a Clinical Professor in the Department of Health Professions at the Creighton University School of Medicine in Omaha, Nebraska. Dr. Brower is a medical geneticist and, for sixteen years, was the Principal Investigator of the NBSTRN, part of the NICHD’s Hunter Kelly Newborn Screening Research Program, at the American College of Medical Genetics and Genomics. She led a team focusing on informatics platforms to enhance the understanding of genetic diseases by managing clinical and genomic data. The NBSTRN, in collaboration with various national research efforts, aims to advance newborn and child health through projects like genome sequencing and Duchenne Muscular Dystrophy early detection. Dr. Brower’s extensive research background includes participation in the Human Genome and International HapMap Projects, molecular diagnostics development, and medical device industry contributions. She served on numerous advisory boards and was a founding member of the Secretary’s Advisory Committee on Heritable Disorders in Newborns and Children. Dr. Brower earned her doctorate in Medical Genetics at the University of Nebraska Medical Center. Amy is a parent to a son with Severe Combined Immunodeficiency.
